Olema Pharmaceuticals (OLMA) Debt to Equity (2025 - 2026)
Olema Pharmaceuticals (OLMA) has 2 years of Debt to Equity data on record, last reported at $0.01 in Q1 2026.
- On a quarterly basis, Debt to Equity changed N/A to $0.01 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.01, a N/A change, with the full-year FY2025 number at $0.01, changed N/A from a year prior.
- Debt to Equity reached $0.01 in Q1 2026 per OLMA's latest filing, roughly flat from $0.01 in the prior quarter.
- Over the last five years, Debt to Equity for OLMA hit a ceiling of $0.01 in Q3 2025 and a floor of $0.01 in Q1 2026.